Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein cysteine thiol groups, also known as sulfhydryl groups, are highly reactive chemical moieties found on the side chains of cysteine residues within a vast array of enzymes and structural proteins. These groups are essential for numerous biological processes, including serving as catalytic centers for enzymes such as cysteine proteases and phosphatases, and participating in the formation of stabilizing disulfide bridges (Giles et al., 2003). They also act as critical sensors in redox signaling pathways, where their oxidation state can regulate protein activity in response to cellular stress (NIH). Because of their nucleophilic nature, these thiol groups are primary targets for covalent modification by various therapeutic agents and environmental toxins. For example, the drug disulfiram treats alcoholism by covalently modifying the thiol groups of aldehyde dehydrogenase, while proton pump inhibitors like omeprazole inhibit gastric acid secretion by binding to cysteines on the H+/K+-ATPase (PubChem; DrugBank). However, the non-specific binding of heavy metals such as mercury, lead, and arsenic to these thiol groups across multiple enzymes is a major driver of systemic toxicity and metabolic disruption (StatPearls). In modern pharmacology, specific cysteine thiols are often targeted by “targeted covalent inhibitors” to achieve high potency and prolonged duration of action in treating cancers and autoimmune diseases. Overall, while these thiol groups are vital for protein function and regulation, their high reactivity makes them a significant focal point for both drug development and toxicological study.
Covalent modification of the nucleophilic sulfhydryl group on cysteine residues via alkylation, oxidation, or metal coordination, which results in the inhibition of enzymatic activity or alteration of protein structure and function.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein cysteine thiol group (Cys-SH).